Cargando…

AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles

It has been widely acknowledged that anti-Müllerian hormone (AMH) is a golden marker of ovarian reserve. Declined ovarian reserve (DOR), based on experience from reproductive-aged women, refers to both the quantitative and qualitative reduction in oocytes. This view is challenged by a recent study c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Xiuliang, Wang, Yufeng, Yang, Haiyan, Gao, Tingting, Yu, Chunmei, Cao, Fang, Xia, Xiyang, Wu, Jun, Zhou, Xianju, Chen, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661530/ https://www.ncbi.nlm.nih.gov/pubmed/33184364 http://dx.doi.org/10.1038/s41598-020-76543-y

Ejemplares similares

Sperm enrichment from poor semen samples by double density gradient centrifugation in combination with swim-up for IVF cycles
por: Dai, Xiuliang, et al.
Publicado: (2020)

The role of FSH to AMH ratio in poor prognosis patients undergoing ICSI cycle
por: Gözükara, İlay, et al.
Publicado: (2022)

Coenzyme Q10 Supplementation and Oocyte Aneuploidy in Women Undergoing IVF–ICSI Treatment
por: Bentov, Yaakov, et al.
Publicado: (2014)

Prediction of metaphase II oocytes according to different serum Anti-Müllerian hormone (AMH) levels in antagonist ICSI cycles
por: da Silva, Joyce B, et al.
Publicado: (2016)

Analysis of ovarian reserve markers (AMH, FSH, AFC) in different age strata in IVF/ICSI patients
por: Shahrokh Tehraninezhad, Ensieh, et al.
Publicado: (2016)

Role of N-acetylcysteine treatment in women with advanced age undergoing IVF/ICSI cycles: A prospective study
por: Li, Xiufang, et al.
Publicado: (2022)

Outcome of conventional IVF and ICSI on sibling oocytes in moderate ligoasthenozoospermia
por: Xie, Bao-Guo, et al.
Publicado: (2013)

Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles
por: Tsai, Tzung-En, et al.
Publicado: (2022)

Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI
por: Rogenhofer, Nina, et al.
Publicado: (2022)

Prediction of ovarian response in IVF/ICSI cycles
por: Cortés-Vazquez, Alfredo, et al.
Publicado: (2021)

What if all the Follicles were already Ruptured at the Time of Oocyte Pick-up in an IVF/ICSI Cycle?
por: Cok, Tayfun
Publicado: (2022)

Efficiency and safety of vitrification of surplus oocytes following superovulation: a comparison of different clinical indications of oocyte cryopreservation in IVF/ICSI cycles
por: Fu, Xiao, et al.
Publicado: (2023)

Comparison of clinical outcomes between in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in IVF-ICSI split insemination cycles
por: Lee, Sun Hee, et al.
Publicado: (2017)

Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study
por: Wu, Yaoqiu, et al.
Publicado: (2021)

Obstetrical and Perinatal Outcomes Are Not Associated with Advanced Paternal Age in IVF or ICSI Pregnancies with Autologous Oocytes
por: Navarro-Gomezlechon, Ana, et al.
Publicado: (2023)

Oocytes with a Dark Zona Pellucida Demonstrate Lower Fertilization, Implantation and Clinical Pregnancy Rates in IVF/ICSI Cycles
por: Shi, Wei, et al.
Publicado: (2014)

Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis
por: Yuwen, Tianyi, et al.
Publicado: (2023)

FSH versus AMH: age-related relevance to ICSI results
por: Salama, Sameh, et al.
Publicado: (2021)

Different methods of pain relief for IVF and ICSI oocyte retrieval – A Dutch survey
por: Roest, Inez, et al.
Publicado: (2019)

The role of serum vitamin D in patients with normal ovarian reserve undergoing the first IVF/ICSI cycle
por: Luo, Rong, et al.
Publicado: (2023)

IVF or ICSI for fertility preservation?
por: Aggarwal, Bhorika, et al.
Publicado: (2021)

Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence
por: Li, Anji, et al.
Publicado: (2020)

Should ICSI be implemented on patients with poor-quality embryos in the previous IVF cycle?
por: Wang, Jiang, et al.
Publicado: (2023)

Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Piette, Paul C M
Publicado: (2021)

Can repeat IVF/ICSI cycles compensate for the natural decline in fertility with age? an estimate of cumulative live birth rates over multiple IVF/ICSI cycles in Chinese advanced-aged population
por: Gu, Fang, et al.
Publicado: (2021)

Live birth following IVF/ICSI using oocytes from donor who was conceived via IVF: a case report
por: Kavoussi, Shahryar K., et al.
Publicado: (2015)

Impact of endometriosis on oocyte morphology in IVF-ICSI: retrospective study of a cohort of more than 6000 mature oocytes
por: Robin, Camille, et al.
Publicado: (2021)

Follicular-fluid anti-Mullerian hormone (FF AMH) is a plausible biochemical indicator of functional viability of oocyte in conventional in vitro fertilization (IVF) cycles
por: Mehta, Bindu N, et al.
Publicado: (2013)

Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Broekmans, Frank, et al.
Publicado: (2021)

AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cycles
por: Li, Howard J., et al.
Publicado: (2023)

The Effect of Four Different Gonadotropin Protocols on Oocyte and Embryo Quality and Pregnancy Outcomes in IVF/ICSI Cycles; A Randomized Controlled Trial
por: Parsanezhad, Mohammad Ebrahim, et al.
Publicado: (2017)

Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles
por: Vanni, V. S., et al.
Publicado: (2017)

Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
por: Xing, Weijie, et al.
Publicado: (2015)

Optimisation of the follicular phase in IVF/ICSI
por: Blockeel, C.
Publicado: (2012)

The Presence of Immature GV− Stage Oocytes during IVF/ICSI Is a Marker of Poor Oocyte Quality: A Pilot Study
por: Astbury, Pia, et al.
Publicado: (2020)

Cleavage speed and implantation potential of early-cleavage embryos in IVF or ICSI cycles
por: Lee, Meng-Ju, et al.
Publicado: (2012)

The Effects of ISM1 Medium on Embryo Quality and Outcomes of IVF/ICSI Cycles
por: Hassani, Fatemeh, et al.
Publicado: (2013)

Evaluation of pretreatment with Cetrotide in an antagonist protocol for patients with PCOS undergoing IVF/ICSI cycles: a randomized clinical trial
por: Eftekhar, Maryam, et al.
Publicado: (2018)

Reduced developmental competence of immature, in-vitro matured and postovulatory aged mouse oocytes following IVF and ICSI
por: Lacham-Kaplan, Orly, et al.
Publicado: (2008)

Trends in research on pain relief during oocyte retrieval for IVF/ICSI: a systematic, methodological review
por: Buisman, E T I A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmou3v10okfomdqmpslvhogj3a